Global Bacterial Partnering Deal Trends, Players and Financials Analysis 2010-2016

Feb 04, 2016, 07:10 ET from Research and Markets

DUBLIN, Feb. 4, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Global Bacterial Partnering 2010-2016: Deal trends, players and financials" company profile to their offering.

Global Bacterial Partnering 2010 to 2016 provides the full collection of Bacterial disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Bacterial disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Bacterial deals.

The report presents financial deal terms values for Bacterial deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Global Bacterial Partnering 2010 to 2016 includes:

  • Trends in Bacterial dealmaking in the biopharma industry since 2010
  • Analysis of Bacterial deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Bacterial deal contract documents
  • Comprehensive access to over 3500 Bacterial deal records
  • The leading Bacterial deals by value since 2010
  • Most active Bacterial dealmakers since 2010

In Global Bacterial Partnering 2010 to 2016, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets